Applied DNA Sciences announced the signing of a five-year license and commercialization agreement for its CertainT traceability platform with Indus Group. Financial terms of the Agreement were not disclosed. Under the terms of the agreement, Applied DNA will supply Indus with its CertainT platform for non-home, cotton-based products originating from Indus facilities in Pakistan, Egypt, and Jordan. Indus will have exclusive use of the platform in these countries and non-exclusive use elsewhere.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APDN:
- Applied DNA Sciences announces U.S. DLA exercises one-year option period
- Applied DNA, Alphazyme conclude Linea RNAP manufacturing scale-up project
- Applied DNA Sciences partners with GenXys Health Care Systems
- Applied DNA Sciences receives approval for TR8 PGx teging service
- Applied DNA Sciences price target lowered to $1.50 from $7 at H.C. Wainwright